Healthcare

Jeffrey Jensen, MD, contextualizes contraceptive efficacy in modern trials

The Pearl Index reported for the newly FDA-approved norelgestromin and ethinyl estradiol transdermal system (Gwyn Lo; Viatris) reflects a shift in how contraceptive efficacy is measured in modern US trials rather than a signal clinicians should find concerning, according to Jeffrey Jensen, MD, MPH, Professor, Obstetrics & Gynecology, Oregon Health & Science University. The discussion continues Jensen's reaction to the FDA approval of the once-weekly patch.1
Read More

Trump Administration Cancels Teen Pregnancy Prevention Funding

Since June 2026, the current administration has canceled 53 Teen Pregnancy Prevention Program (TPP) grants totaling $67 million. Instead, they are being replaced with programs focused on  “anatomy, fertility tracking, hormonal production, and ‘reproductive goals counseling.” The Department of Health and Human Services (HHS) justified the cuts by arguing that the previous programs “normalized sexual activity for minors.’ 
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.